Patients with symptomatic valvular heart disease requiring intervention are at high-risk of severe evolution in case of COVID-19 infection.
Strict individual protective measures are advised. The heart team discussion is key regarding individual decisions.
In most cases, less symptomatic patients will be delayed, while more symptomatic patients will be treated.